Bal Pharma Board Meeting Scheduled for May 27, 2026

• Bal Pharma Ltd schedules board meeting on May 27, 2026, to approve FY26 audited financial results and accounts.
• The board will consider recommending a dividend for FY26 and appointing Internal & Cost Auditors for FY 2025-26.
• Approval for granting employee stock options under the 'Bal Pharma Ltd — Employee Stock Option Plan -2025' is on the agenda.
• The company's insider trading window was closed from April 1 to May 29, 2026, surrounding the results announcement.